Gene · 7468
Papers2,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of Multiple Myeloma: Clinical Implications. | Hematol Oncol Clin North Am | 2024 | 38199896 | PubTator, text mining | PubMed |
| CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy. | EBioMedicine | 2024 | 38199044 | PubTator, text mining | PubMed |
| Uncovering hidden cancer self-dependencies through analysis of shRNA-level dependency scores. | Sci Rep | 2024 | 38195844 | PubTator, text mining | PubMed |
| Genomic Classification and Individualized Prognosis in Multiple Myeloma. | J Clin Oncol | 2024 | 38194610 | PubTator, text mining | PubMed |
| NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1. | Pharmacol Res | 2024 | 38190956 | PubTator, text mining | PubMed |
| SIRT1 activated by AROS sensitizes glioma cells to ferroptosis via induction of NAD+ depletion-dependent activation of ATF3. | Redox Biol | 2024 | 38181705 | PubTator, text mining | PubMed |
| Genetic and prognostic analysis of blastoid and pleomorphic mantle cell lymphoma: a multicenter analysis in China. | Ann Hematol | 2024 | 38165416 | PubTator, text mining | PubMed |
| Research progress of extracellular vesicles in the treatment of ovarian diseases (Review). | Exp Ther Med | 2024 | 38125352 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of eukaryotic initiation factor 3 subunit E (eIF3E) by lysine methyltransferase REIIBP confers a pro-inflammatory phenotype in t(4;14) myeloma. | Haematologica | 2024 | 38124661 | PubTator, text mining | PubMed |
Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations. | J Enzyme Inhib Med Chem | 2024 | 38059332 | PubTator, text mining | PubMed |
| The differentiation courses of the Tfh cells: a new perspective on autoimmune disease pathogenesis and treatment. | Biosci Rep | 2024 | 38051200 | PubTator, text mining | PubMed |
| TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway. | Dig Dis Sci | 2024 | 38007701 | PubTator, text mining | PubMed |
| Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent. | Cell Death Differ | 2024 | 38001255 | PubTator, text mining | PubMed |
| Identification of potential phytochemical for the inhibition of non-muscle invasive bladder cancer (NMIBC). | J Biomol Struct Dyn | 2024 | 37962848 | PubTator, text mining | PubMed |
| ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37934799 | PubTator, text mining | PubMed |
| USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression. | Mol Oncol | 2024 | 37867415 | PubTator, text mining | PubMed |
| Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37767768 | PubTator, text mining | PubMed |
| SETDB1-mediated CD147-K71 di-methylation promotes cell apoptosis in non-small cell lung cancer. | Genes Dis | 2024 | 37692516 | PubTator, text mining | PubMed |
| NUP98 rearrangements in AML: molecular mechanisms and clinical implications. | Onco (Basel) | 2023 | 42164049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7468/papers?page=9